To compare the rate of adverse perinatal outcomes among women with gestational diabetes mellitus (GDM), monitored by 1 versus 2 hourpostprandial glucose (PPG) measurements.
INTRODUCTION
Gestational diabetes mellitus (GDM) complicates about 3 to 5% of all pregnancies and is associated with an increase in perinatal morbidity. 1 A substantial portion of the neonatal morbidities associated with GDM are related to excessive fetal growth. It has been shown that insulin-treated GDM women managed according to results of 1-hour postprandial glucose (PPG) levels achieved a greater decrease in HbA1c and had significantly less macrosomic infants when compared to those managed by preprandial glucose levels. 2 Although there is evidence to suggest that lowering postprandial blood glucose level will reduce the risk of macrosomia and other perinatal complications in GDM, controlled trials to identify ideal glycemic targets have not been performed [3] [4] [5] [6] [7] and no study to date has demonstrated the superiority of one postmeal testing schedule over another. The Fourth International Workshop Conference on GDM recommended that blood glucose levels should be measured after meals in addition to fasting. 8, 9 What has not been established, however, is the best timing of the postprandial measurements, that is, 1 or 2 hours after meals. Both the ADA and ACOG have suggested that the threshold of 140 mg/dl at 1 hour (1 h-PPG) or 120 mg/dl at 2 hours (2 h-PPG) is to be used as the glycemic targets to reduce the risk of macrosomia. 8, 9 These recommendations represent lack of data to favor one method (1 h-PPG) over the other (2 h-PPG). Since we have demonstrated that 1-and 2-hour PPG measurements do not yield the same diurnal rate of pathologic values (hence, one method might impose stricter targets as compared to the other), 10, 11 we have postulated that altering the timing of postprandial measurements might have an impact on the perinatal outcome.
Therefore, we undertook the current study to determine if the timing of measurements might have an effect on perinatal outcomes. It was the purpose of this study to compare the rate of adverse perinatal outcome between women with GDM monitored by 1-versus 2-hour PPG measurements. It was our hypothesis that 1-hour PPG levels more closely reflect overall glycemic control, and therefore, the rate of macrosomia and other adverse neonatal outcomes would be lower in women performing 1-versus 2-hour postmeal glucose determinations.
METHODS
A total of 122 consecutive pregnancies referred to our diabetesin-pregnancy program between May, 1999 and April, 2000 were included in this prospective study. The Sheba Medical Center Institutional Review Board approved the study. All women were diagnosed with gestational diabetes based on the criteria of Carpenter and Coustan. 12 The women were recruited from two free standing outpatient prenatal clinics in the suburbs surrounding Tel Aviv. Both clinics were staffed by the same team of health-care professionals and were managed using a standardized protocol (described below). Historically, GDM patients in one treatment center were managed by 1-hour PPG measurements while women at the other center were managed by 2-hour measurements, creating the opportunity for an observational study to examine the impact of timing on perinatal outcomes. Glucose levels were measured at fasting, and either 1 hour (1-hour monitoring group) or 2 hours (2-hour monitoring group) postprandially, and were determined by the setting in which the women received their prenatal care. The two populations were homogeneous in terms of ethnicity and socioeconomic status. Women with pregestational diabetes or fasting glucose levels of 105 mg/dl and above were excluded from the study due to initiation of insulin treatment.
On admission, all women were seen by a registered dietitian for individualized counseling and instruction. Women were placed on 1800-2200 calorie ADA diet with the following composition: 40 to 45% carbohydrates, 20% protein and r40% fat. All women were given a memory-based blood glucose meter (One Touch Profile r , LifeScan, Inc.) and were instructed to measure capillary blood glucose. Glucose levels were measured at fasting and either 1 hour (1-hour monitoring group; target values <140 mg/dl) or 2 hours (2-hour monitoring group; target values <120 mg/dl) postprandially. Blood glucose levels, which were provided as plasma equivalents, were downloaded directly from the glucose meter to a PC in our clinic and were then stored for further analysis (In Touch, LifeScan, Inc.). Quality control measures were performed on the meters prior to implementation and again at study completion. It was our policy to initiate insulin therapy when capillary blood levels exceeded 95 mg/dl at fasting (both groups) or postprandial levels exceeded threshold levels (140 mg/dl 1-hour monitoring group and 120 mg/dl 2-hour monitoring group) in more than 30% of measurements. Patients were routinely followed up by the outpatient clinic. Induction of labor was suggested based on obstetrical indications. Otherwise, we had a policy of induction of labor at full 41 weeks of pregnancy or when the estimated fetal weight was about 4000 g. Relevant medical history (i.e. history of GDM, family history of diabetes) and maternal and neonatal outcome variables were collected from medical records throughout the pregnancy and at the first postpartum visit. Statistical analysis was performed using Student's t-test, w 2 , and multiple regressions. Statistical significance was set at p<0.05.
RESULTS
A total of 122 women were included in this study. Four women were excluded from the study due to twin pregnancies. Six women were lost to follow up. The only data from the remaining 112 patients were analyzed. Allocation to treatment group was based on the setting in which women received their prenatal care. In all, 66 patients were assigned to 1-hour monitoring group (1 h-PPG) and 46 were assigned to 2-hour monitoring group (2 h-PPG). The social background and demographics of the two groups did not differ except for a small-unexplained difference in the age of the women between the two groups, with women in the 2-hour monitoring group being older. However, there was no difference in parity, family history of diabetes, GDM in previous pregnancies, weight and pre-and postgestational BMI. Both groups had similar 50-g GCT and 100-g OGIT (Table 1) . Glycemic control, as expressed by HbA1c levels, was similar in both groups (5.3 and 5.2% for 1-and 2-hour monitoring group, respectively, p ¼ 0.34).
The mean gestational age at delivery in our study was similar in both groups (39.5±1.7 and 39.1±1.4 weeks; p ¼ 0.17). Perinatal outcomes defined as gestational week at delivery, fetal weight, weight percentile at delivery and rate of macrosomia (>4000 g) and large for gestational age (LGA >90th percentile) were evaluated for both groups (Table 2) . Gestational age at delivery and mean birth weights were similar in the two groups. The rates of macrosomia (7.5 versus 10.6%) and LGA (7.4 versus 15.2%) were increased among the newborns in group 2; however, these differences were not statistically significant. Neonatal birth weight was significantly correlated with maternal weight gain during pregnancy ( p ¼ 0.001) and a family history of diabetes ( p ¼ 0.02). The 2-hour monitoring group had a higher rate of delivery by cesarean section; however, this increase was not statistically significant (Table 2) . Significantly, more women in the 2-hour PPG group required insulin therapy (28 versus 40%, p ¼ 0.031). Interestingly, the family history of DM was significantly associated to initiation of insulin treatment in both centers ( p ¼ 0.011). There were no cases of Erb's palsy or significant fetal hypoglycemia in the study population.
DISCUSSION
In this study, we have compared perinatal outcome between patients monitored by 1-and 2-hour PPG measurements. The same team of health-care professionals managed the two groups, and management decisions (i.e. initiation of insulin therapy and indications for induction of labor) were made using a standardized protocol. The difference in the size of the two groups is related to the size of the respective perinatal centers and is not related to preliminary sorting by clinical criteria. Indeed, the two groups had a small difference in age; however, there were no differences in other factors that might be related to the severity of the disease (Table 1) . Furthermore, glucose levels during glucose challenge test and glucose tolerance test were similar in both groups, suggesting similar levels of glucose sensitivity between both groups. The two groups also had similar levels of pathologic measurements during the study period.
It must be noted that the prevailing assumption is that a 1-hour value of 140 mg/dl reflects the same level of glucose control as a blood glucose level of 120 mg/dl at 2 hours. 7, 9 However, if in fact one target represents a stricter standard of control than the other target, the validity of our results is weakened. Since there are no data to confirm or refute this assumption, we based our study on the commonly held practice of their comparability.
The perinatal outcomes that were evaluated in this study included fetal weight (and percentile), rate of macrosomia and LGA, rate of insulin therapy during pregnancy and rate of cesarean section. In order to evaluate other important but less common events such as shoulder dystocia, Erb's Palsy and fetal death, the groups would have needed to be much larger.
Fetal weight in GDM serves as a reflection of the quality of glucose control. It has been shown that patients with poorly controlled glucose levels have relatively larger fetuses. [3] [4] [5] [6] 10, 12 Moreover, overly strict control might increase the rate of small for gestational age (SGA) fetuses. 13 In our study, patients managed by 2-hour PPG had a higher (nonsignificant) rate of macrosomic and LGA fetuses. These data might suggest that 1-hour PPG measurements are a better reflection of overall glycemic control than are 2-hour values. We have initiated insulin therapy (when appropriate diet failed to achieve glycemic control) significantly more often in the 2-hour monitoring group (Table 2) . We postulate that 1-hour postprandial measurements may provide a more effective threshold for initiating dietary adjustments, thus reducing the need for insulin therapy. However, it is also possible that the 2-hour PPG reflects a tighter cutoff value than the 1-hour PPG levels. Therefore, these assumptions should be evaluated in future studies assessing different PPG cutoffs (as the common 130 mg/dl 1-hour PPG).
The rate of cesarean section was 24 and 30% in groups 1 and 2, respectively, and was similar to that reported in the literature. 14 Other investigators have noted a high rate of cesarean delivery among women with GDM despite normal birth weights. Some experts have suggested that the diagnosis of gestational diabetes itself shifts obstetric practice toward operative delivery because of its association with macrosomia and birth trauma. 15 To conclude, patients monitored by 1-hour PPG measurements were less likely to require insulin treatment during pregnancy. As far as the most common adverse perinatal outcome is concerned, management of GDM by 1-hour PPG measurements yields a clinically significant albeit not statistically signification reduction in the rate of LGA newborns. Not surprisingly, the rate of cesarean section was also increased among women in the 2-h-PPG group since they were more likely to give birth to macrosomic and LGA infants. We believe that the superiority of one monitoring schedule over the other should be further evaluated prospectively in large controlled trials; preferentially where each woman will serve as her own control (by monitoring both 1-and 2-hours PPG levels) and then be appointed to management according to the specific schedule regimens. It is worth noting that, in order to assess the less common perinatal complications such as hyaline membrane disease, Erb's Palsy, fractured clavicles, fetal anomalies and stillbirth, a much larger sample size is required. Therefore, until larger prospective controlled trials are introduced, both methods of follow-up are compatible. However, due to less usage of insulin treatment and a reduced rate of LGA, we feel that the 1-hour schedule seems superior. In our opinion, any clinical scheme must take into account lifestyle considerations and patient preferences. It has been our experience as well as others 16, 17 that women prefer 1-to 2-hour determinations. The closer proximity of testing to meals interferes less with their normal daily activities. It is also our experience that the longer the time between the meals and the determinations of blood glucose levels, the more likely women are to forget, thereby leading to reduced regimen compliance.
